Thromb Haemost 2007; 97(04): 678-680
DOI: 10.1160/TH06-12-0711
Letters to the Editor
Schattauer GmbH

Influence of PROS1 gene mutations affecting protein S amino-acid 275 on plasma free protein S measurement

Martine Alhenc Gelas
1   AP-HP, Hôpital Européen Georges Pompidou, Service d’Hématologie Biologique A, Paris, France
,
Fabrice Juin
2   AP-HP, Hôtel-Dieu, Laboratoire d’Hématologie, Paris, France
,
Emmanuelle de Raucourt
3   Centre Hospitalier, Laboratoire d’Hématologie, St-Germain-en-Laye, France
,
Sophie Gandrille
1   AP-HP, Hôpital Européen Georges Pompidou, Service d’Hématologie Biologique A, Paris, France
,
Delphine Borgel
1   AP-HP, Hôpital Européen Georges Pompidou, Service d’Hématologie Biologique A, Paris, France
,
Martine Aiach
1   AP-HP, Hôpital Européen Georges Pompidou, Service d’Hématologie Biologique A, Paris, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 12. Dezember 2006

Accepted after revision 28. Januar 2007

Publikationsdatum:
24. November 2017 (online)

 

 
  • References

  • 1 Gandrille S, Borgel D, Ireland H. et al. for the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Protein S deficiency: a database of mutations. Thromb Haemost 1997; 77: 1201-1214.
  • 2 Bertina RM, Ploos Van Amstel A, Van Wijngaarden A. et al. Herleen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-548.
  • 3 Espinosa-Parrilla Y, Navarro G, Morell M. et al. Homozygosity for the protein S Herleen allele is associated with type I PS deficiency in a thrombophilic pedigree with multiple risk factors. Thromb Haemost 2000; 83: 102-106.
  • 4 Giri TK, Yamazaki T, Sala N. et al. Deficient APCcofactor activity of protein S Herleen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors. Blood 2000; 96: 523-531.
  • 5 Gandrille S, Borgel D, Eschwege Gufflet V. et al. Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 1995; 85: 130-138.
  • 6 Okada H, Yamazaki T, Takagi A. et al. In vitro characterization of missense mutations associated with quantitative protein S deficiency. J Thromb Haemost 2006; 4: 2003-2009.
  • 7 Villoutreix BO, Dahlbäck B, Borgel D. et al. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights. Proteins 2001; 43: 203-216.
  • 8 He X, Dahlbäck B. Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S. Eur J Biochem 1993; 217: 857-865.
  • 9 Giri TK, Linse S, Garcia de Frutos P. et al. Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-bindig protein. J Biol Chem 2002; 17: 15099-15106.
  • 10 Serra J, Sales M, Chitolie A. et al. Multicentre evaluation of IL test free PS. Thromb Haemost 2000; 88: 975-983.
  • 11 Borgel D, Reny JL, Fischelis D. et al. Cleaved protein S, total PS, free PS, and activated protein C cofactor activity as risk factors for venous thrombosis. Clin Chem 2003; 49: 575-580.
  • 12 Giri TK, Hillarp A, Hardig Y. et al. A new direct, fast and quantitative enzyme-linked ligand sorbent assay for measurement of free protein S antigen. Thromb Haemost 1998; 79: 767-772.
  • 13 Comp PC, Doray D, Patton D. et al. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986; 67: 504-508.
  • 14 Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-1174.
  • 15 Lane DA, Mannucci PM, Bauer KA. et al. Inherited thrombophilia: part 2. Thromb Haemost 1996; 76: 824-834.
  • 16 Goodwin AJ, Rosendaal FR, Kottke-Marchant K. et al. A review of the technical, diagnostic, and epidemiological considerations for protein S assays. Arch Pathol Lab Med 2002; 126: 1349-1366.